New hope for kids with tough blood cancers: trial tests Triple-Drug attack
NCT ID NCT07175415
Summary
This trial is testing whether a combination of three drugs—capivasertib, venetoclax, and dexamethasone—is safe and effective for children and young adults whose leukemia or lymphoma has returned or hasn't responded to standard treatments. The study will first find the safest dose and then see how well the treatment works to control the cancer. It is for patients aged 2 to 21 years old with specific types of blood cancers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.